EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association Study

Yujia Zhao iD, Yunjia Lai iD, Sirwan K L Darweesh iD, Bastiaan R Bloem, Lars Forsgren, Johnni Hansen, Verena A Katzke, Giovanna Masala, Sabina Sieri, Carlotta Sacerdote, Salvatore Panico, Raul Zamora-Ros und 9 weitere

Movement Disorders · 2025-03 · 40 (3) · 556-560

DOI: 10.1002/mds.30054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 12.11.2024. Verfasst von Yujia Zhao und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Parkinson Disease, Gastrointestinal Microbiome, Metabolome. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ZonMw, Edmond J Safra Foundation, Stichting ParkinsonFonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alterations in gut microbiota are observed in Parkinson's disease (PD). Previous studies on microbiota‐derived metabolites in PD were small‐scale and post‐diagnosis, raising concerns about reverse causality.

Objectives

Our goal was to prospectively investigate the association between plasma microbial metabolites and PD risk within a metabolomics framework.

Methods

A nested case–control study within the prospective EPIC4PD cohort, measured pre‐diagnostic plasma microbial metabolites using untargeted metabolomics.

Results

Thirteen microbial metabolites were identified nominally associated with PD risk ( P ‐value < 0.05), including amino acids, bile acid, indoles, and hydroxy acid, although none remained significant after multiple testing correction. Three pathways were implicated in PD risk: valine, leucine, and isoleucine degradation, butanoate metabolism, and propanoate metabolism. PD‐associated microbial pathways were more pronounced in men, smokers, and overweight/obese individuals.

Conclusion

Changes in microbial metabolites may represent a pre‐diagnostic feature of PD. We observed biologically plausible associations between microbial pathways and PD, potentially influenced by individual characteristics. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseGastrointestinal MicrobiomeMetabolomeHumansMaleFemaleMiddle AgedAgedCase-Control StudiesMetabolomicsProspective StudiesRisk Factors

Stichwörter der Autor:innen

gut‐brain axis; microbial metabolites; Parkinson's disease; pre‐diagnostic bios…

Autor:innen und Institutionen

  • Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
  • Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York City, USA.
  • Radboud University Medical Center; Donders Institute for Brain, Cognition and Behavior; Department of Neurology, Center of Expertise for Parkinson and Movement Disorders, Nijmegen, The Netherlands.
  • Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden.
  • Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
  • Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

ORCID-Profile: Yujia Zhao, Yunjia Lai, Sirwan K L Darweesh, Susan Peters

Förderung

  • ZonMw
  • Edmond J Safra Foundation
  • Stichting ParkinsonFonds
  • Deutsche Forschungsgemeinschaft
  • ParkinsonNL
  • Michael J. Fox Foundation for Parkinson's Research
  • NIEHS NIH HHS
  • Parkinson's Foundation

Zitieren

APA

Zhao, Y., Lai, Y., Darweesh, S. K. L., Bloem, B. R., Forsgren, L., Hansen, J., Katzke, V. A., Masala, G., Sieri, S., Sacerdote, C., Panico, S., Zamora-Ros, R., Sánchez, M. J., Huerta, J. M., Guevara, M., Vinagre-Aragon, A., Vineis, P., Lill, C. M., Miller, G. W., …, & Vermeulen, R. (2025). Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association Study. Movement Disorders, 40(3), 556-560. https://doi.org/10.1002/mds.30054

Vancouver

Zhao Y, Lai Y, Darweesh SKL, Bloem BR, Forsgren L, Hansen J, et al. Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association Study. Movement Disorders. 2025;40(3):556-560. doi:10.1002/mds.30054

BibTeX
@article{Zhao2025,
  author = {Zhao, Yujia and Lai, Yunjia and Darweesh, Sirwan K L and Bloem, Bastiaan R and Forsgren, Lars and Hansen, Johnni and Katzke, Verena A and Masala, Giovanna and Sieri, Sabina and Sacerdote, Carlotta and Panico, Salvatore and Zamora-Ros, Raul and Sánchez, Maria-Jose and Huerta, José María and Guevara, Marcela and Vinagre-Aragon, Ana and Vineis, Paolo and Lill, Christina M and Miller, Gary W and Peters, Susan and Vermeulen, Roel},
  title = {Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association Study},
  journal = {Movement Disorders},
  year = {2025},
  volume = {40},
  number = {3},
  pages = {556--560},
  doi = {10.1002/mds.30054}
}
Kostenlos starten →